Want to see IN:JYOTHYLAB full AI Analyst Report?
Top Page
Jyothy Labs Limited
(JYOTHYLAB)
Select Model
Select Model
Rating:69Neutral
Price Target:
₹218.00
▲(9.77% Upside)
Action:Downgraded
Date:08/17/26
The score is driven primarily by solid financial quality (low leverage, strong ROE, and positive free cash flow), partially offset by recent margin compression and weaker cash conversion consistency. Technicals are subdued with the stock trading below key longer-term moving averages and only mild momentum. Valuation is moderate-to-premium (P/E ~25.8) with a modest dividend yield, limiting upside if profitability pressure persists.
Positive Factors
Conservative Balance Sheet
Minimal leverage reduces financial risk and interest burden, giving Jyothy Labs flexibility to invest in brands, distribution and innovation. Consistently strong mid-teens to above 20% ROE also indicates that the company has historically generated attractive returns on its capital base.
Negative Factors
Margin Compression
Lower margins despite higher revenue indicate that rising input costs, weaker product mix or limited pricing power are reducing operating leverage. If this persists, profitability and reinvestment capacity could remain below the levels implied by the company’s otherwise solid business quality.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Minimal leverage reduces financial risk and interest burden, giving Jyothy Labs flexibility to invest in brands, distribution and innovation. Consistently strong mid-teens to above 20% ROE also indicates that the company has historically generated attractive returns on its capital base.
Read all positive factors
Jyothy Labs Limited (JYOTHYLAB) vs. iShares MSCI India ETF (INDA)
Market Cap
₹71.75B
Dividend Yield1.79%
Average Volume (3M)261.05K
Price to Earnings (P/E)25.3
Beta (1Y)0.98
Revenue Growth3.85%
EPS Growth-22.29%
CountryIN
Employees2,970
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)7.74
Shares Outstanding367,214,500
10 Day Avg. Volume469,482
30 Day Avg. Volume261,049
Financial Highlights & Ratios
PEG Ratio-2.15
Price to Book (P/B)4.56
Price to Sales (P/S)2.46
P/FCF Ratio20.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.1
Revenue Forecast (FY)₹30.20B
Jyothy Labs Limited Business Overview & Revenue Model
Company Description
Jyothy Labs Limited, along with its affiliated companies, is a prominent manufacturer and marketer of diverse consumer products. Operating both domestically within India and in international markets, the company specializes in categories such as f...
How the Company Makes Money
Jyothy Labs makes money primarily by selling branded FMCG products in India, generating revenue from the invoiced sale of finished goods to distributors, retailers, and other channel partners (and, where applicable, directly to certain institution...
Jyothy Labs Limited Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
86
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.84B | 29.44B | 28.68B | 27.61B | 24.86B | 21.97B |
| Gross Profit | 11.36B | 9.80B | 14.39B | 13.48B | 10.42B | 9.06B |
| EBITDA | 4.48B | 5.17B | 5.05B | 4.74B | 3.08B | 2.39B |
| Net Income | 2.84B | 3.33B | 3.70B | 3.69B | 2.40B | 1.62B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 22.52B | 26.91B | 24.01B | 20.62B | 20.23B |
| Cash, Cash Equivalents and Short-Term Investments | 8.15B | 8.16B | 5.99B | 6.16B | 2.81B | 2.09B |
| Total Debt | 0.00 | 515.80M | 612.80M | 505.60M | 465.30M | 1.71B |
| Total Liabilities | -15.89B | 6.64B | 6.41B | 5.91B | 5.11B | 6.20B |
| Stockholders Equity | 15.89B | 15.89B | 20.50B | 18.08B | 15.49B | 14.44B |
Cash Flow | ||||||
| Free Cash Flow | 1.61B | 3.58B | 2.53B | 4.21B | 2.93B | 1.77B |
| Operating Cash Flow | 1.96B | 4.25B | 3.11B | 4.58B | 3.29B | 2.03B |
| Investing Cash Flow | -1.17B | -2.94B | -1.61B | -3.44B | -482.90M | -317.13M |
| Financing Cash Flow | -1.44B | -1.55B | -1.57B | -1.35B | -2.51B | -1.67B |
Jyothy Labs Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹1.05T | 55.08 | ― | 0.50% | 25.00% | 12.83% | |
69 Neutral | ₹71.75B | 25.28 | ― | 1.79% | 3.85% | -22.29% | |
69 Neutral | ₹4.57T | 30.51 | ― | 2.12% | 3.83% | 38.55% | |
68 Neutral | ₹885.16B | 46.49 | ― | 2.28% | 9.22% | 3.19% | |
65 Neutral | ₹659.91B | 33.85 | ― | 2.19% | 7.40% | 10.63% | |
57 Neutral | ₹247.37B | 28.73 | ― | 3.87% | -1.54% | -4.58% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:JYOTHYLAB
Jyothy Labs Limited
195.65
-123.83
-38.76%
IN:DABUR
Dabur India Limited
377.50
-156.81
-29.35%
IN:GODREJCP
Godrej Consumer Products Limited
871.00
-374.05
-30.04%
IN:HINDUNILVR
Hindustan Unilever Limited
1,937.50
-597.47
-23.57%
IN:MARICO
Marico Limited
802.00
71.14
9.73%
IN:PGHH
Procter & Gamble Hygiene & Health Care Ltd.
7,584.10
-5,406.25
-41.62%
Jyothy Labs Limited Corporate Events
Jyothy Labs conducts 35th AGM via virtual platform with nearly 48% equity represented
Jul 14, 2026
Jyothy Labs Limited held its 35th Annual General Meeting on July 14, 2026, conducted entirely via video conferencing and other audio-visual means in line with Ministry of Corporate Affairs guidelines. The meeting was chaired by Chairperson and Man...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.